Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Assessing PDL principles and factors
This document includes guidance for companies (applicants) who wish to put forward submissions/applications to request a switch of an ingredient from prescription to non-prescription status.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-11-01
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Assessing PDL principles and factors (French, HTML) HTML
- Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Assessing PDL principles and factors (English, HTML) HTML